Adoption of intensity-modulated radiation therapy for breast cancer in the United States

Journal of the National Cancer Institute

Volumn 103, Issue 10, 2011, Pages 798-809

  Smith, Benjamin D ^a   Pan, I Wen ^a   Shih, Ya Chen T ^a   Smith, Grace L ^a   Harris, Jay R ^b   Punglia, Rinaa ^b   Pierce, Lori J ^c   Jagsi, Reshma ^c   Hayman, James A ^c   Giordano, Sharon H ^a   Buchholz, Thomas A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BILLING AND CLAIMS; BREAST CANCER; CANCER PATIENT; FEMALE; HEALTH CARE COST; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MEDICARE; PRIORITY JOURNAL; REIMBURSEMENT; UNITED STATES;

AGED; BREAST NEOPLASMS; FEMALE; HEALTH CARE COSTS; HUMANS; LOGISTIC MODELS; LYMPHATIC METASTASIS; MEDICARE; MULTIVARIATE ANALYSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; REIMBURSEMENT MECHANISMS; SEER PROGRAM; TREATMENT OUTCOME; UNITED STATES;

EID: 79957533093     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djr100     Document Type: Article

References (42)

1. Smith BD, Haffty BG, Wilson LD, Smith GL, Patel AN, Buchholz TA. The future of radiation oncology in the United States from 2010 to 2020: Will supply keep pace with demand? J Clin Oncol. 2010;28(35):5160-5165.
2. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differ-ences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet. 2005;366(9503):2087-2106. (Pubitemid 41797643)
3. Shapiro CL, Recht A. Side effects of adjuvant treatment of breast cancer. N Engl J Med. 2001;344(26):1997-2008. (Pubitemid 32568155)
4. Jagsi R. Breast. In: Shrieve D, Loeffler J, eds. Human Radiation Injury. Philadelphia, PA: Lippincott, Williams, and Wilkins; 2010.
5. White J, Joiner MC. Toxicity from radiation in breast cancer. Cancer Treat Res. 2006;128:65-109.
6. Ahunbay EE, Chen GP, Thatcher S, et al. Direct aperture optimization-based intensity-modulated radiotherapy for whole breast irradiation. Int J Radiat Oncol Biol Phys. 2007;67(4):1248-1258.
7. Bhatnagar AK, Brandner E, Sonnik D, et al. Intensity modulated radiation therapy (IMRT) reduces the dose to the contralateral breast when com-pared to conventional tangential fields for primary breast irradiation. Breast Cancer Res Treat. 2006;96(1):41-46.
8. Beckham WA, Popescu CC, Patenaude VV, Wai ES, Olivotto IA. Is mul-tibeam IMRT better than standard treatment for patients with left-sided breast cancer? Int J Radiat Oncol Biol Phys. 2007;69(3):918-924. (Pubitemid 47418420)
9. Cho BC, Schwarz M, Mijnheer BJ, Bartelink H. Simplified intensity-modulated radiotherapy using pre-defined segments to reduce cardiac complications in left-sided breast cancer. Radiother Oncol. 2004;70(3):231-241. (Pubitemid 38520154)
10. Pignol JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol. 2008;26(13):2085-2092.
11. Donovan E, Bleakley N, Denholm E, et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol. 2007;82(3):254-264. (Pubitemid 46341474)
12. Coles CE, Barnett GC, Wilkinson JS, et al. A randomised controlled trial of forward-planned intensity modulated radiotherapy (IMRT) for early breast cancer: Interim results at 2 years follow-up. Cancer Res. 2009;69(24 suppl):71.
13. de la Torre N, Figueroa CT, Martinez K, Riley S, Chapman J. A compar-ative study of surface dose and dose distribution for intact breast following irradiation with field-in-field technique vs. the use of conventional wedges. Med Dosim. 2004;29(2):109-114. (Pubitemid 38748876)
14. Ercan T, Igdem S, Alco G, et al. Dosimetric comparison of field in field intensity-modulated radiotherapy technique with conformal radiotherapy techniques in breast cancer. Jpn J Radiol. 2010;28(4):283-289.
15. Lee JW, Hong S, Choi KS, et al. Performance evaluation of field-in-field technique for tangential breast irradiation. Jpn J Clin Oncol. 2008;38(2):158-163. (Pubitemid 351337962)
16. Mihai A, Rakovitch E, Sixel K, et al. Inverse vs. forward breast IMRT planning. Med Dosim. 2005;30(3):149-154. (Pubitemid 41160454)
17. Murthy KK, Sivakumar SS, Davis CA, Ravichandran R, El Ghamrawy K. Optimization of dose distribution with multi-leaf collimator using field-in-field technique for parallel opposing tangential beams of breast cancers. J Med Phys. 2008;33(2):60-63.
18. Ohashi T, Takeda A, Shigematsu N, et al. Dose distribution analysis of axillary lymph nodes for three-dimensional conformal radiotherapy with a field-in-field technique for breast cancer. Int J Radiat Oncol Biol Phys. 2009;73(1):80-87.
19. Prabhakar R, Julka PK, Rath GK. Can field-in-field technique replace wedge filter in radiotherapy treatment planning: A comparative analysis in various treatment sites. Australas Phys Eng Sci Med. 2008;31(4):317-324.
20. Suh WW, Pierce LJ, Vicini FA, Hayman JA. A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2005;62(3):790-796. (Pubitemid 40779770)
21. Berenson RA. Implementing health care reform-why Medicare matters. N Engl J Med. 2010;863(2):101-103.
22. http://www.seer.cancer.gov/. Accessed July 20, 2008.
23. Fritz A, Percy C, Jack A, et al. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
24. Medicare Coverage Database. http://www.cms.gov/mcd, www.cms.gov/mcd. Accessed July 15, 2010.
25. Makuc DM, Haglund B, Ingram DD, Kleinman JC, Feldman JJ. Health service areas for the United States. National Center for Health Statistics. Vital Health Stat. 1991;(2):112.
26. Osborne C, Ostir GV, Du X, Peek MK, Goodwin JS. The influence of marital status on the stage at diagnosis, treatment, and survival of older women with breast cancer. Breast Cancer Res Treat. 2005;93(1):41-47. (Pubitemid 41355989)
27. Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ. Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol. 2006;24(1):85-94. (Pubitemid 46630498)
28. Bach PB, Guadagnoli E, Schrag D, Schussler N, Warren JL. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care. 2002;40(8 suppl):IV19-IV25.
29. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40(5):373-383. (Pubitemid 17055592)
30. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
31. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives. J Clin Epidemiol. 1993;46(10):1075-1079; discussion 1081-1090.
32. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53(12):1258-1267. (Pubitemid 32007842)
33. Klabunde CN, Warren JL, Legler JM. Assessing comorbidity using claims data: An overview. Med Care. 2002;40(8 suppl):IV26-IV35.
34. Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care. 2002;40(8 suppl):IV104-IV117.
35. Warren JL, Yabroff KR, Meekins A, Topor M, Lamont EB, Brown ML. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst. 2008;100(12):888-897. (Pubitemid 351881955)
36. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Handbook. 6th ed. New York, NY: Springer; 2002.
37. Barber JA, Thompson SG. Analysis of cost data in randomized trials: An ap-plication of the non-parametric bootstrap. Stat Med. 2000;19(23):3219-3236.
38. Gawande A. The cost conundrum: What a Texas town can teach us about health care. 2009. http://www.newyorker.com/reporting/2009/06/01/090601fa-fact- gawande. Accessed Aug 18, 2010.
39. Smith BD, Smith GL, Roberts KB, Buchholz TA. Baseline utilization of breast radiotherapy prior to institution of the Medicare Practice Quality Reporting Initiative. Int J Radiat Oncol Biol Phys. 2009;74(5):1506-1512.
40. Krauss DJ, Kestin LL, Raff G, et al. MRI-based volumetric assessment of cardiac anatomy and dose reduction via active breathing control during irradiation for left-sided breast cancer. Int J Radiat Oncol Biol Phys. 2005;61(4):1243-1250. (Pubitemid 40340920)
41. Remouchamps VM, Vicini FA, Sharpe MB, Kestin LL, Martinez AA, Wong JW. Significant reductions in heart and lung doses using deep in-spiration breath hold with active breathing control and intensity-modu-lated radiation therapy for patients treated with locoregional breast irradiation. Int J Radiat Oncol Biol Phys. 2003;55(2):392-406. (Pubitemid 36069098)
42. Du X, Freeman JL, Goodwin JS. Information on radiation treatment in patients with breast cancer: The advantages of the linked medicare and SEER data. Surveillance, Epidemiology and End Results. J Clin Epidemiol. 1999;52(5):463-470. (Pubitemid 29305352)